Ergoteles’s Inozyme Pharma INZY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-25,649
Closed -$122K 1740
2022
Q2
$122K Buy
+25,649
New +$122K ﹤0.01% 1466
2022
Q1
Sell
-12,200
Closed -$83K 1419
2021
Q4
$83K Buy
+12,200
New +$83K ﹤0.01% 1164